Marklife Medic Pharma Group Co., Limited
大民工程有限公司
Marklife Medic Pharma Group Co., Limited (大民工程有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its official Company Registration Number (CR) is 1620264, and Business Registration Number (BRN) is 58552144, classified as a Private company limited by shares. Incorporated on 2026-02-06, the entity has maintained continuous statutory operations for 1 year, currently holding an active legal status of Live. The registered office is situated at 香港 葵涌 大連排道21-33號 宏達工業中心 11樓11室,12室,13A室,13B室,19A室,19B室. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.
I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 大民工程有限公司 | Official English Name | Marklife Medic Pharma Group Co., Limited |
|---|---|---|---|
| Former Legal Names |
Former Name
Makelife Medic Pharma Group Co., Limited
|
||
| Business Reg No. (BRN) | 58552144 | Company Reg No. (CR) | 1620264 |
| Company Category | Private company limited by shares | Incorporation Date | 2026-02-06 |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-02-06 |
| Registered Office Address |
香港 葵涌 大連排道21-33號 宏達工業中心 11樓11室,12室,13A室,13B室,19A室,19B室
|
||
| Significant Controllers (SCR) | Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers. | ||
II. Companies Registry Statutory Image Records
Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.
| Item | Filing Date | Form Ref. | Document Name | Pages | Format | Fee | Action |
|---|---|---|---|---|---|---|---|
| 1 | 2026-02-15 | ND2A |
ND2A Statutory Filing
|
4 | ¥28.00 | ||
| 2 | 2026-02-06 | A&A |
A&A Statutory Filing
|
32 | ¥28.00 | ||
| 3 | 2026-02-06 | NNC1 |
NNC1 Statutory Filing
|
22 | ¥28.00 | ||
| 4 | 2026-02-06 | NAR1 |
NAR1 Statutory Filing
|
16 | ¥28.00 |
III. Commercial Due Diligence & Regulatory Risk Screening
Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.
IV. Similar Trade Names & Industry Directory
ZENO IMPORT AND EXPORT CO…
JAPAN TENGRAN SHANCHUAN Z…
日本藤壤山川株式会社有限公司
Mingyuanda Limited
铭远达有限公司
ZIYI CAPITAL LIMITED
子弋资本有限公司
Jasmine International Acc…
君美国际会计有限公司
New Hui Horizon Limited
万界汇有限公司